Geode Capital Management’s Qualigen Therapeutics QLGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-45,759
| Closed | -$7.8K | – | 4500 |
|
|
2024
Q3 | $7.8K | Buy |
45,759
+15,544
| +51% | +$2.65K | ﹤0.01% | 4496 |
|
|
2024
Q2 | $5.21K | Sell |
30,215
-11,680
| -28% | -$2.02K | ﹤0.01% | 4575 |
|
|
2024
Q1 | $16.3K | Hold |
41,895
| – | – | ﹤0.01% | 4506 |
|
|
2023
Q4 | $23K | Hold |
41,895
| – | – | ﹤0.01% | 4490 |
|
|
2023
Q3 | $42.3K | Buy |
41,895
+19,743
| +89% | +$19.9K | ﹤0.01% | 4458 |
|
|
2023
Q2 | $20.2K | Sell |
22,152
-177
| -0.8% | -$161 | ﹤0.01% | 4657 |
|
|
2023
Q1 | $20.7K | Sell |
22,329
-335
| -1% | -$310 | ﹤0.01% | 4699 |
|
|
2022
Q4 | $29K | Sell |
22,664
-204,007
| -90% | -$261K | ﹤0.01% | 4712 |
|
|
2022
Q3 | $60K | Hold |
226,671
| – | – | ﹤0.01% | 4725 |
|
|
2022
Q2 | $129K | Buy |
226,671
+14,047
| +7% | +$7.99K | ﹤0.01% | 4482 |
|
|
2022
Q1 | $140K | Hold |
212,624
| – | – | ﹤0.01% | 4529 |
|
|
2021
Q4 | $227K | Sell |
212,624
-8,522
| -4% | -$9.1K | ﹤0.01% | 4418 |
|
|
2021
Q3 | $287K | Buy |
221,146
+52,444
| +31% | +$68.1K | ﹤0.01% | 4292 |
|
|
2021
Q2 | $335K | Buy |
168,702
+15,804
| +10% | +$31.4K | ﹤0.01% | 4119 |
|
|
2021
Q1 | $412K | Buy |
152,898
+29,863
| +24% | +$80.5K | ﹤0.01% | 3873 |
|
|
2020
Q4 | $370K | Buy |
123,035
+56,729
| +86% | +$171K | ﹤0.01% | 3695 |
|
|
2020
Q3 | $328K | Buy |
+66,306
| New | +$328K | ﹤0.01% | 3571 |
|
|
2018
Q1 | – | Sell |
-29,614
| Closed | -$9K | – | 4069 |
|
|
2017
Q4 | $9K | Hold |
29,614
| – | – | ﹤0.01% | 4010 |
|
|
2017
Q3 | $10K | Hold |
29,614
| – | – | ﹤0.01% | 4040 |
|
|
2017
Q2 | $16K | Hold |
29,614
| – | – | ﹤0.01% | 4056 |
|
|
2017
Q1 | $42K | Hold |
29,614
| – | – | ﹤0.01% | 3971 |
|
|
2016
Q4 | $80K | Buy |
+29,614
| New | +$80K | ﹤0.01% | 3829 |
|